192 related articles for article (PubMed ID: 37065996)
41. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
42. [A case of hepatoid adenocarcinoma of the stomach].
Takahashi M; Shida T; Otsuka Y; Ogasawara T; Nakano S; Nomura S; Takahashi M; Kondo F; Miyazaki M
Gan To Kagaku Ryoho; 2012 Feb; 39(2):285-7. PubMed ID: 22333645
[TBL] [Abstract][Full Text] [Related]
43. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
Kang GH; Kim YI
Virchows Arch; 1998 Jan; 432(1):85-7. PubMed ID: 9463592
[TBL] [Abstract][Full Text] [Related]
44. Hepatoid adenocarcinoma of the stomach: A case report and literature review.
Liu XM; Chen GQ; Li SL; Zai TS
Exp Ther Med; 2015 Jun; 9(6):2133-2136. PubMed ID: 26136947
[TBL] [Abstract][Full Text] [Related]
45. Refractory solitary cervical lymph node metastasis after esophageal squamous cell carcinoma surgery and its successful treatment with immune checkpoint inhibitor: A case report and literature review.
Song W; Wang H; Tian Y; Liu S; Chen X; Cui J; Zhao Y
Medicine (Baltimore); 2020 Mar; 99(10):e19440. PubMed ID: 32150096
[TBL] [Abstract][Full Text] [Related]
46. Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Emir S; Karakurt N; Karakuş E; Şenel E; Kırsaçlıoğlu C; Demir HA; Orhan D
Turk J Pediatr; 2014; 56(1):88-91. PubMed ID: 24827954
[TBL] [Abstract][Full Text] [Related]
47. Liver Metastasis of Hepatoid Colonic Adenocarcinoma: A Rare and Unusual Entity With Poor Prognosis and Review of the Literature.
Hu M; Liu W; Yin F; Zhang D; Liu X; Lai J
Gastroenterology Res; 2018 Dec; 11(6):430-435. PubMed ID: 30627268
[TBL] [Abstract][Full Text] [Related]
48. Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report.
Urushibara M; Ishizaka K; Matsutani N; Takahashi M; Nagata M; Okumura T; Matsumoto Y; Tatsuoka S; Nenohi T; Amemiya T; Shimizu Y; Shirakawa T; Kato D
World J Surg Oncol; 2023 Feb; 21(1):37. PubMed ID: 36747242
[TBL] [Abstract][Full Text] [Related]
49. Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report.
Li J; Qi H; Xu B; Zhao J; Gao H; Ma X; Liu X
Front Oncol; 2019; 9():1360. PubMed ID: 31921629
[TBL] [Abstract][Full Text] [Related]
50. Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
Morinaga S; Takahashi Y
Jpn J Clin Oncol; 1996 Aug; 26(4):258-63. PubMed ID: 8765186
[TBL] [Abstract][Full Text] [Related]
51. Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
Takano M; Shibasaki T; Sato K; Aida S; Kikuchi Y
Gynecol Oncol; 2003 Nov; 91(2):444-8. PubMed ID: 14599882
[TBL] [Abstract][Full Text] [Related]
52. Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Lin CW; Hsu CC; Chang HC; Sun YC; Sun PL; Hsu CY; Perng DS
Cases J; 2009 Aug; 2():6317. PubMed ID: 19918575
[TBL] [Abstract][Full Text] [Related]
53. Hepatoid Adenocarcinoma of the Lung.
Li M; Fan Y; Lu H
Technol Cancer Res Treat; 2021; 20():15330338211057983. PubMed ID: 34816785
[TBL] [Abstract][Full Text] [Related]
54. Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report.
de Castria TB; Tang L; Queiroz MM; Awni BM; Paroder V; Shamseddine A; Bariani GM; Mukherji D; Matar CF; Fernandes GDS; El-Olayan A; Sabatin F; Elias R; Gupta R; Janjigian YY; Abou-Alfa GK
J Gastrointest Oncol; 2021 Dec; 12(6):3123-3132. PubMed ID: 35070435
[TBL] [Abstract][Full Text] [Related]
55. Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report.
Liu R; Wang X; Ji Z; Deng T; Li HL; Zhang YH; Yang YC; Ge SH; Zhang L; Bai M; Ning T; Ba Y
World J Clin Cases; 2022 Jun; 10(18):6184-6191. PubMed ID: 35949814
[TBL] [Abstract][Full Text] [Related]
56. Locally advanced gastroesophageal junction cancer with pathological complete response to neoadjuvant therapy: a case report and literature review.
Li X; Huang Q; Lei Y; Zheng X; Dai S; Leng W; Liu M
Ann Transl Med; 2021 Mar; 9(6):513. PubMed ID: 33850910
[TBL] [Abstract][Full Text] [Related]
57. Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma.
Takamochi K; Hara K; Hayashi T; Kohsaka S; Takahashi F; Suehara Y; Suzuki K
Lung Cancer; 2021 Nov; 161():163-170. PubMed ID: 34600407
[TBL] [Abstract][Full Text] [Related]
58. Case Report: An "Immune-Cold" EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy.
Zhao Q; Zhang X; Ma Q; Luo N; Liu Z; Wang R; He Y; Li L
Front Oncol; 2022; 12():765997. PubMed ID: 35273908
[TBL] [Abstract][Full Text] [Related]
59. A 49-year-old woman presenting with hepatoid adenocarcinoma of the urinary bladder: a case report.
Sekino Y; Mochizuki H; Kuniyasu H
J Med Case Rep; 2013 Jan; 7():12. PubMed ID: 23302376
[TBL] [Abstract][Full Text] [Related]
60. Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer.
Wang L; Feng Y; Huang A; Shi J; Zhang Q; Zhu F; Lv B; Guo F; Zou T; Zhang L
Front Oncol; 2022; 12():962126. PubMed ID: 36387141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
